2021
DOI: 10.1186/s42358-020-00160-6 View full text |Buy / Rent full text
|
|

Abstract: Spondyloarthritis (SpA) is a group of chronic inflammatory systemic diseases characterized by axial and/or peripheral joints inflammation, as well as extra-articular manifestations. Over some decades, nonsteroidal anti-inflammatory drugs (NSAIDs) have been the basis for the pharmacological treatment of patients with axial spondyloarthritis (axSpA). However, the emergence of the immunobiologic agents brought up the discussion about the role of NSAIDs in the management of these patients. The objective of this gu… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
1
0
0
1

Publication Types

Select...

Relationship

0
0

Authors

Journals